Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cancer Profiling Market Size Changed, over the years?

In recent years, the market size for cancer profiling has seen significant growth. It is projected to expand from $13.48 billion in 2024 to $15.05 billion in 2025, representing a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the past include an uptick in the rates of cancer diagnosis, an increase in the precision of medicine techniques, clinical usage of biomarkers, the development of drugs and targeted therapies as well as increased public awareness and advocacy for patients.

How Much Will the Cancer Profiling Market Be Worth in 2029?

The market size for cancer profiling is predicted to experience a swift expansion in the following years, reaching $23.08 billion in 2029, boasting a compound annual growth rate (CAGR) of 11.3%. The anticipated growth during the forecast period is linked to the inclusion of artificial intelligence, worldwide research partnerships, broadening the usage of liquid biopsy applications, regulatory backing for precision medicine, and a growing focus on early detection. The major market trends for the forecast period include the dominance of liquid biopsy, comprehensive genomic profiling, the rise of immunoprofiling, the growth of collaborative data sharing networks, and single-cell sequencing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9912&type=smp

Which is the Largest Company in the Cancer Profiling Market?

Major companies operating in the cancer profiling market include Illumina Inc., Qiagen NV, NeoGenomics Inc., Sysmex Corporation, HTG Molecular Diagnostics Inc., Caris Life Sciences, NanoString Technologies Inc., Guardant Health Inc., Foundation Medicine Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs Inc., Hologic Inc., Predictive Oncology Inc., Abbott Laboratories, Agilent Technologies Inc., PerkinElmer Inc., Siemens Healthineers, Genomic Health Inc., Natera Inc., ArcherDX Inc., Personal Genome Diagnostics Inc., Enzo Biochem Inc., Cancer Genetics Inc., OncoDNA SA, Ribomed Biotechnologies Inc., Biocartis Group NV, N-of-One Inc., Cynvenio Biosystems Inc., Inivata Ltd., Burning Rock Biotech Limited, PathAI Inc., GENEWIZ Inc., Genoptix Inc., Oncomine Dx Target Test, OmniSeq Comprehensive, Resolution Bioscience, OncoCyte Corporation

What Are the Main Market Drivers in the Cancer Profiling Industry?

The rise in cancer prevalence is forecasted to boost the expansion of the cancer profiling market. The term “cancer incidence” refers to the number of new cancer diagnoses within a certain population over a specific duration. This surge in cancer cases can be attributed to urbanization, an increasing elderly population, lifestyle changes, as well as environmental and genetic aspects. Cancer profiling helps detect specific changes in a tumor’s molecular makeup, including gene mutations or changes in the tumor’s DNA, which greatly aids in the treatment process in cancer care. For example, in 2022, the American Cancer Society, a voluntary organization based in the U.S., predicted around 1.9 million new cancer diagnoses and approximately 609,360 cancer-related fatalities in the United States. Hence, this rising prevalence of cancer is fuelling the growth of the cancer profiling market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9912&type=smp

How Is the Cancer Profiling Market Segments Structured?

The cancer profiling market covered in this report is segmented –

1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization

2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers

4) By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications

Subsegments:

1) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting, Luminex xMAP Technology, Radioimmunoassays

2) By PCR (Polymerase Chain Reaction): Quantitative PCR (qPCR), Digital PCR (dPCR), Reverse Transcription PCR (RT-PCR)

3) By NGS (Next-Generation Sequencing): Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, RNA Sequencing (RNA-Seq)

4) By Microarrays: DNA Microarrays, RNA Microarrays, SNP Arrays

5) By In-Situ Hybridization: Fluorescence In-Situ Hybridization (FISH), Chromogenic In-Situ Hybridization (CISH)

What Strategic Trends Are Transforming the Cancer Profiling Market?

Prominent companies in the cancer profiling industry are emphasizing innovation such as extensive coverage in their developments. This testing method examines 517 genes pertinent to cancer across almost 30 different types of solid tumors. Comprehensive or extensive coverage involves an all-inclusive examination of a variety of genetic mutations, biomarkers, or molecular targets. For instance, Illumina, Inc., a biotech company based in the US, debuted the TruSight Oncology Comprehensive (TSO) test in March 2022, marking a considerable progression in cancer diagnosis. This new diagnostic test for in vitro use in Europe identifies cancer mutations to guide patients towards specific therapies. It scans 517 genes across close to 30 types of solid tumors, analyzing both DNA and RNA. With a turnaround of four to five days, the test delivers results faster and complies with European quality standards marked by CE, meeting the demand for multiple gene tests on different tissue samples.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report

Which Global Regions Offer the Highest Growth in the Cancer Profiling Market?

North America was the largest region in the cancer profiling market in 2024. The regions covered in the cancer profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9912

This Report Delivers Insight On:

1. How big is the cancer profiling market, and how is it changing globally?

2. Who are the major companies in the cancer profiling market, and how are they performing?

3. What are the key opportunities and risks in the cancer profiling market right now?

4. Which products or customer segments are growing the most in the cancer profiling market?

5. What factors are helping or slowing down the growth of the cancer profiling market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model